Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 19

Trial Status

Completed3
Recruiting3
Terminated2
Other2

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT07778524Phase 1Recruiting
Alpelisib Challenge Test (ACT)
Healthy Adult ParticipantsInsulin ResistanceObesity & Overweight+1 more
PrincipalinvestigatorStart date: 2026-09-02
NCT07403604Phase 1Recruiting
Effect of Insulin Lowering on Lipogenesis
HyperinsulinemiaInsulin ResistanceNon-Alcoholic Fatty Liver Disease+2 more
PrincipalinvestigatorStart date: 2026-07-01
NCT06606327Phase 1Terminated
Diazoxide Suppression Test P&F Study
HyperinsulinemiaInsulin ResistanceObesity
PrincipalinvestigatorStart date: 2024-10-23
NCT06592261Phase 1Completed
Graded Insulin Suppression Test P&F
HealthyHyperinsulinemiaInsulin Resistance+1 more
PrincipalinvestigatorStart date: 2024-09-16
NCT06354088Phase 1Recruiting
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Insulin ResistanceNon-Alcoholic Fatty Liver DiseaseOverweight and Obesity+1 more
PrincipalinvestigatorStart date: 2024-04-24
NCT06242847Terminated
Role of Insulin Action in Psoriasis Pathogenesis
Insulin ResistanceOverweight and ObesityPlaque Psoriasis+2 more
PrincipalinvestigatorStart date: 2024-02-02
NCT05729282Phase 1Completed
Glycemic Effect of Diazoxide in NAFLD
HyperinsulinemiaInsulin ResistanceNon-Alcoholic Fatty Liver Disease+1 more
PrincipalinvestigatorStart date: 2023-08-01
NCT05733455Phase 1Completed
Effect of Alpelisib in Healthy Volunteers
DyslipidemiasHyperinsulinemiaInsulin Resistance
PrincipalinvestigatorStart date: 2023-05-09
NCT06126354Phase 1Withdrawn
Dexamethasone/Pancreatic Clamp P&F
Insulin ResistanceNon-Alcoholic Fatty Liver DiseaseOverweight and Obesity+1 more
Principalinvestigator
NCT06558422Phase 1Not Yet Recruiting
Human Models of Selective Insulin Resistance: Pancreatic Clamp
HyperinsulinemiaInsulin ResistanceMetabolic Dysfunction Associated Steatotic Liver Disease+3 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

HealthyPrediabetic StateDiabetes Mellitus, Type 2+2 more
Similarity Score11%

Samuel Klein, MD

Washington University School of Medicine

Related
30 trials

Shared therapeutic areas:

ObesityInsulin ResistanceNon-alcoholic Fatty Liver Disease+2 more

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score11%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

ObesityNon-alcoholic Fatty Liver DiseasePsoriasis+1 more
Similarity Score9%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

PsoriasisDiabetes Mellitus, Type 2Obesity+1 more
Similarity Score9%

ali ismail, lecturer

Cairo University

Related
29 trials

Shared therapeutic areas:

ObesityPsoriasisDiabetes Mellitus, Type 2+1 more
Similarity Score9%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityHealthyInsulin Resistance

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score6%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Healthy
Similarity Score4%

David s Ludwig, MD, PhD

Boston Children's Hospital

Related
17 trials

Shared therapeutic areas:

ObesityInsulin Resistance

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score4%

Britt Burton-Freeman, ph.D

Illinois Institute of Technology

Related
23 trials

Shared therapeutic areas:

HealthyPrediabetic State
Similarity Score4%

Nanette Santoro, MD

University of Colorado, Denver

Related
13 trials

Shared therapeutic areas:

ObesityHyperinsulinism
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT07778524Phase 1PrincipalInvestigator

Alpelisib Challenge Test (ACT)

Healthy Adult ParticipantsInsulin ResistanceObesity & Overweight+1 more
Recruiting
NCT07403604Phase 1PrincipalInvestigator

Effect of Insulin Lowering on Lipogenesis

HyperinsulinemiaInsulin ResistanceNon-Alcoholic Fatty Liver Disease+2 more
Recruiting
NCT06606327Phase 1PrincipalInvestigator

Diazoxide Suppression Test P&F Study

HyperinsulinemiaInsulin ResistanceObesity
Terminated
NCT06592261Phase 1PrincipalInvestigator

Graded Insulin Suppression Test P&F

HealthyHyperinsulinemiaInsulin Resistance+1 more
Completed
NCT06354088Phase 1PrincipalInvestigator

Human Models of Selective Insulin Resistance: Alpelisib, Part I

Insulin ResistanceNon-Alcoholic Fatty Liver DiseaseOverweight and Obesity+1 more
Recruiting
NCT06242847PrincipalInvestigator

Role of Insulin Action in Psoriasis Pathogenesis

Insulin ResistanceOverweight and ObesityPlaque Psoriasis+2 more
Terminated
NCT05729282Phase 1PrincipalInvestigator

Glycemic Effect of Diazoxide in NAFLD

HyperinsulinemiaInsulin ResistanceNon-Alcoholic Fatty Liver Disease+1 more
Completed
NCT05733455Phase 1PrincipalInvestigator

Effect of Alpelisib in Healthy Volunteers

DyslipidemiasHyperinsulinemiaInsulin Resistance
Completed
NCT06126354Phase 1PrincipalInvestigator

Dexamethasone/Pancreatic Clamp P&F

Insulin ResistanceNon-Alcoholic Fatty Liver DiseaseOverweight and Obesity+1 more
Withdrawn
NCT06558422Phase 1PrincipalInvestigator

Human Models of Selective Insulin Resistance: Pancreatic Clamp

HyperinsulinemiaInsulin ResistanceMetabolic Dysfunction Associated Steatotic Liver Disease+3 more
Not Yet Recruiting

All 10 trials loaded